{"schema_version":"secwatch.filing_event.v1","accession":"0001062993-25-013468","form_type":"8-K","ticker":"MDCX","cik":"0001997296","company_name":"Medicus Pharma Ltd.","filed_at":"2025-08-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.781870+00:00","generated_at":"2026-05-17T21:37:42.100041+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Medicus Pharma signs non-binding MoU with HelixNano for thermostable mRNA vaccine development","bullets":["Non-binding MoU to combine Medicus' MNA delivery platform with HelixNano's mRNA platform for thermostable infectious disease vaccines.","Parties aim to form a joint venture for co-development and commercialization of thermostable mRNA-based vaccines.","Plan a Phase 1 bridging study comparing IM injection vs. intradermal MNA delivery of HelixNano's vaccine candidate HN-0001.","Preliminary activities include a Sponsored Research Agreement with University of Pittsburgh (Dr. Lou Falo), supply of HN-0001, and loading into Medicus' MNAs.","MoU is non-binding; no obligation to proceed with joint venture until definitive agreements are executed."],"urls":{"canonical":"https://secwatch.observer/filing/0001062993-25-013468","json":"https://secwatch.observer/filing/0001062993-25-013468.json","markdown":"https://secwatch.observer/filing/0001062993-25-013468.md","text":"https://secwatch.observer/filing/0001062993-25-013468.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325013468/0001062993-25-013468-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1997296/000106299325013468/form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T21:37:42.100041+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}